Trial Profile
Ultra-Long-Acting Insulin Degludec Has a Flat and Stable Glucose-Lowering Effect
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Jul 2011
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 06 Jul 2011 New trial record